Clinical Trial Update: Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating concurrent intensity-modulated radiotherapy with docetaxel and cisplatin or carboplatin, followed by adjuvant chemotherapy, in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Lung Neoplasms | Phase 2 | Status: COMPLETED